The recent dismissal of an employee-led class action lawsuit against Johnson & Johnson (J&J), which alleged mismanagement of the health plan's prescription drug benefit, might give health plan ...
Across the country, health systems are rethinking their reliance on legacy PBMs. Instead of outsourcing, more organizations are bringing PBM functions in-house to take back control, capture savings, ...
Early 2026 marks a coordinated turning point in the federal regulation and oversight of pharmacy benefit managers (PBMs), and these new PBM rules have significant fiduciary implications for ERISA ...
In this Golden Age of government programs, the health plan industry has never had more exposure to the generally poor performance of pharmacy benefit managers (PBMs). Performance metrics in Medicare, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results